Isolated right ventricular failure in scleroderma heart disease

Cardiology in Review

Volumn 12, Issue 5, 2004, Pages 279-281

  George, Benjamin J ^a   Kwan, Michael D ^a   Morris, Michael J ^a  

^a BROOKE ARMY MEDICAL CENTER   (United States)

Author keywords

Echocardiography; Pulmonary hypertension; Right ventricular failure; Scleroderma

Indexed keywords

ADULT; ARTICLE; CASE REPORT; DISEASE ASSOCIATION; ECHOCARDIOGRAPHY; FEMALE; FORCED EXPIRATORY VOLUME; HEART CATHETERIZATION; HEART DISEASE; HEART RIGHT VENTRICLE FAILURE; HUMAN; INTERSTITIAL LUNG DISEASE; LUNG FUNCTION TEST; PULMONARY HYPERTENSION; RHEUMATIC DISEASE; SCLERODERMA; SYNDROME CREST; VASCULAR DISEASE; VASOSPASM;

ADULT; FEMALE; FORCED EXPIRATORY VOLUME; HEART CATHETERIZATION; HUMANS; SCLERODERMA, LOCALIZED; STROKE VOLUME; VENTRICULAR DYSFUNCTION, LEFT; VENTRICULAR DYSFUNCTION, RIGHT; VITAL CAPACITY;

EID: 4344656515     PISSN: 10615377     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.crd.0000134912.95852.db     Document Type: Article

References (18)

1. Owens GR, Follansbee WP. Cardiopulmonary manifestations of systemic sclerosis. Chest. 1987;91:118-127.
2. Longo MJ, Remetz MS. Cardiovascular manifestations of systemic autoimmune diseases. Clin Chest Med. 1998;19:793-808.
3. Coghlan JG, Mukerjee D. The heart and pulmonary vasculature in scleroderma: clinical features and pathobiology. Curr Opin Rheumatol. 2001;13:495-499.
4. MacGregor AJ, Canavan R, Knight C, et al. Pulmonary hypertension in systemic sclerosis: risk factors for progression and consequences for survival. Rheumatology. 2001;40:453-459.
5. Badesch DB, Tapson VF, McGoon MD, et al. Continuous intravenous epoprostenol for pulmonary hypertension due to scleroderma spectrum of disease: a randomized, controlled trial. Ann Intern Med. 2000;132:425-434.
6. Bettoni L, Geri A, Airo P, et al. Systemic sclerosis therapy with iloprost: A prospective observational study of 30 patients treated for a median of 3 years. Clin Rheumatol. 2002;21:244-250.
7. Bewley AP, Cooper JP, Nevell NJ, et al. Systemic sclerosis associated with right ventricular cardiomyopathy. Br J Dermatol. 1996;134:1141-1143.
8. Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 4-1999. A 38-year-old woman with increasing pulmonary hypertension after delivery. N Engl J Med. 1999;340:455-464.
9. Ballou SP, Morley JJ, Kushner I. Pregnancy and systemic sclerosis. Arthritis Rheum. 1984;27:295-298.
10. D'Angelo WA, Fries JF, Masi AT, et al. Pathologic observations in systemic sclerosis (scleroderma). A study of fifty-eight autopsy cases and fifty-eight matched controls. Am J Med. 1969;46:428-440.
11. Vlachoyiannopoulos P, Dafni U, Pakas I, et al. Systemic scleroderma in Greece: low mortality and strong linkage with HLA-DRB1-1104 allele. Ann Rheum Dis. 2000;59:359-367.
12. Bulkley BH, Ridolfi RL, Salyer WR, et al. Myocardial lesions of progressive systemic sclerosis. A cause of cardiac dysfunction. Circulation. 1976;53:483-490.
13. Follansbee WP, Curtiss EI, Medsger TA. Physiological abnormalities of cardiac function in progressive systemic sclerosis with diffuse scleroderma. N Engl J Med. 1984;310:142-148.
14. Ishida R, Murata Y, Sawada Y, et al. Thallium-201 myocardial SPET in patients with collagen disease. Nuclear Med Commun. 2000;21:729-734.
15. Chung G, Lahini A. Myocardial perfusion imaging in modern cardiology. Br J Cardiol. 2000;7:619-623.
16. Karwatowski SP, Chronos NA, Sinclaire H, et al. Effect of systemic sclerosis on left ventricular long-axis motion and left ventricular mass assessed by magnetic resonance. J Cardiovasc Magn Reson. 2000;2:109-117.
17. Giunta A, Tirri E, Maione S, et al. Right ventricular diastolic abnormalities in systemic sclerosis. Relation to left ventricular involvement and pulmonary hypertension. Ann Rheum Dis. 2000;59:94-98.
18. Denton CP, Cailes JB, Phillips GD, et al. Comparison of Doppler echocardiography and right heart catheterization to assess pulmonary hypertension in systemic sclerosis. Br J Rheumatol. 1997;36:239-243.